School of Medicine
Showing 301-310 of 1,319 Results
-
Paul Schmiedmayer
Instructor, Computational Medicine
Current Research and Scholarly InterestsDr. Schmiedmayer develops open-source agentic AI systems and multimodal foundation models that transform electronic health records, wearable sensors, and patient-generated data into personalized healthcare. His research builds the next generation of interoperable computational medicine infrastructure, enabling scalable, privacy-preserving, patient-facing AI for cardiometabolic disease prevention and the translation of AI into routine clinical practice.
-
David Schneider
Professor of Microbiology and Immunology
Current Research and Scholarly InterestsWe study innate immunity and microbial pathogenesis. We have been studying models for a variety of bacterial infections including: Listeria, Mycobacteria, Salmonella and Streptococcus as well as some fungi, malaria and viruses. Our current focus is to determine how we recover from infections.
-
Logan Schneider
Adjunct Clinical Associate Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsFrom a research perspective, my long-term career plan is to refine the understanding of normal and dysfunctional sleep, much like the Epilepsy Phenome/Genome Project (EPGP) and Epi4K are doing for the enigmatic epilepsies. Insufficient sleep has been deemed a public health problem with poorly understood behavioral and physiologic sleep disorders lying at the core of the issue. I am currently using well-defined distinct and objective phenotypes (e.g. periodic limb movements, hypocretin-deficient narcolepsy) to acquire the analytic skills necessary to expand my knowledge of both signal processing and genetics, with the former enhancing my ability to identify and/or refine sleep phenotypes, and the latter facilitating the pathophysiological understanding of these phenotypes. As a consequence of a better link between symptoms/phenotypes, physiology, and genetic risks, more personally targeted and effective therapeutics can be developed to address the enriched spectrum of sleep disorders.
